Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2001-09-13
2003-12-23
Ketter, James (Department: 1636)
Chemistry: molecular biology and microbiology
Vector, per se
C435S069100, C536S024100
Reexamination Certificate
active
06667174
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to expression vectors that contain hybrid ubiquitin promoters. The promoters are useful, among other uses, for high and sustained transgene expression in in vivo and ex vivo gene therapy and for recombinant protein expression in vitro.
BACKGROUND OF THE INVENTION
Ubiquitin is an abundant, small, 76 amino acid protein that is expressed in all eukaryotic cells (Ciechanover et al. 2000; Wilkinson et al, 2000). The protein covalently attaches to abnormal, misfolded or short-lived proteins, marking them for destruction in proteasomes (Ciechanover, supra). Ubiquitin also associates with histones and may play a role in the regulation of gene expression (Spencer and Davie, 1999). The coding sequence is remarkably conserved evolutionarily, being identical from insect to man. There are at least three known ubiquitin genes in humans, named UbA, UbB, and UbC, which appear to contain one, three or nine precise direct repeats of the 76 amino acid coding unit, respectively (Baker and Board,
Nucleic Acids Research,
15:443-463 (1987); Lund et al. 1985; Nenoi, et al 1996; and Wiborg et al.,
EMBO J.,
4:755-759 (1985). The human UbB and UbC genes have been sequenced and shown to contain no introns within their coding regions, but each contain an intron in the
5
′ flanking region (Baker and Board, supra; Nenoi supra). The UbC promoter has been shown to provide high level, ubiquitous expression when inserted into transgenic mice and when incorporated into plasmid DNA vectors (Johansen et al.,
FEBS
267:289-294 (1990); Schorpp et al.,
Nucleic Acids Research,
24:1787-1788 (1996); Wulff et al., 1990).
The promoter from human cytomegalovirus (CMV) (see U.S. Pat. Nos. 5,849,522; 5,168,062) is known to provide strong constitutive expression of transgenes at high levels. However, in gene therapy applications, expression levels achieved using the CMV promoter have been shown to be significantly reduced over time.
Accordingly, there remains a need to provide improved regulatory elements that are able to provide high and sustained expression of transgenes in applications such as gene therapy.
SUMMARY OF THE INVENTION
The present invention provides hybrid regulatory regions using elements from one or more ubiquitin promoters together with one or more strong enhancers. The present invention further provides DNA vectors that provide for high and persistent expression of associated coding sequences.
REFERENCES:
Schorpp et al., Nucleic Acids Research, vol. 24, No. 9, 1996, pp. 1787-1788.*
Moser et al., Biotechnol. Prog., vol. 16, Sep. 8, 2000, pp. 724-735.*
Ciechanover, A et al., Ubiquitin-mediated proteolysis: biological regulation via destruction, Bioessays, vol. 22, 2000, pp. 442-451.
Spencer, V. A. et al., Role of covalent modifications of histones in regulating gene expression, Gene, vol. 240, 1999, PP 1-12.
Li, S. et al., Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors, Am. J. Physiol., vol. 276, 1999, pp. L796-804.
Tousignant, J. et al., Comprehensive Analysis of the Acute Toxicities Induced by Systemic Administration of Cationic Lipid:Plasmid DNA Complexes in Mice, Hum. Gene Ther., vol. 11, 2000, PP2493-2513.
Boshart, M. et al., A Very Strong Enhancer Is Located Upstream of an Immediate Early Gene of Human Cytomegalovirus, Cell, vol. 41, 1985, pp. 521-530.
Zweidler-McKay, P.A. et al., Gfi Encodes a Nuclear Zinc Finger Protein That Binds DNA and Functions as a Transcriptional Repressor, Mol. Cell. Biol. vol. 16, No. 8, pp. 4024-4034.
Galvin, K. et al., Multiple Mechanisms of Transcriptional Repression by YY1, Mol. cell. Bio., vol. 17, No. 7, 1997, pp. 3723-3732.
Lee, E. R. et al., Detailed Analysis of Structures and Formulations of Cationic Lipids for Efficient Gene Transfer to the Lung, Hum. Gene Ther., vol. 7, 1996, pp. 1701-1717.
Baker, R. T. et al., The human ubiquitin gene family: structure of a gene and pseudogenes from the Ub B subfamily, Nucleic Acids Res., vol. 15, No. 2, 1987, PP443-463.
Yew, N. S. et al ., Optimization of Plasmid Vectors for High -Level Expression in Lung Epithelial Cells, Hum. Gene Ther., vol. 8, 1997, pp. 575-584.
Genzyme Corporation
Ketter James
LandOfFree
Expression vectors containing hybrid ubiquitin promoters does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Expression vectors containing hybrid ubiquitin promoters, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Expression vectors containing hybrid ubiquitin promoters will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3110632